Showing results for pea1 pea2 peo 152708 152706 152707 152708 155270 155270 152708 152706 152707 peo 152708 152706 152707 152708 155270 155270 152708 152706 152707 152708 152706 152707 152708 155270 155270 152708 152706 152707

PEO1-CDDP Cell Line. Early log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.

PEO1-CDDP Cell Line Product

The PEO1-CDDP Cell Line is an in-vitro model to understand the changes in EGF signalling after the onset of cisplatin resistance.

PEO14 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC)

PEO14 Cell Line Product

The PEO14 cell line is one of nine from the PE ovarian adenocarcinoma panel – derived from 4 patients at varying stages of ovarian cancer

Figure 1. The family tree of A2780 cell sublines with acquired resistance to PTX. A2780 parental cell line and six sublines; chosen for further studies; are bolded. The schedule of PTX treatment for each cell line is described as e.g. (4+7+27)d* - 4 days of 2 nM PTX treatment; 7 days of recovery and 27 days of 2 nM PTX retreatment; totally 31 days of drug treatment were needed for cell adaptation to 2 nM PTX concentration. Reprinted from Szenajch J. et al. 2020. Int. J. Mol. Sci. 21(23)

A2780 PTX(4) resistant cell line Product

[…] (inverse resistance) has been developed by continuous growing of A2780 parental cell line (cat. no 152706) in step-wise increases of PTX doses (0.25 nM – 0.5 nM – 1 nM- […]

TO14 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC).

TO14 Cell Line Product

[…] with a well differentiated serous adenocarcinoma. This cell line is from the same patient as PEO14 and PEO23 cell lines and is a oestrogen receptor negative cell line. TO14 cell […]